HCA Healthcare, Inc. $HCA Shares Purchased by Wealthfront Advisers LLC

Wealthfront Advisers LLC increased its position in shares of HCA Healthcare, Inc. (NYSE:HCA) by 38.8% in the 4th quarter, Holdings Channel.com reports. The firm owned 30,303 shares of the company’s stock after acquiring an additional 8,463 shares during the quarter. Wealthfront Advisers LLC’s holdings in HCA Healthcare were worth $14,147,000 at the end of the most recent quarter.

Several other hedge funds and other institutional investors have also recently bought and sold shares of HCA. Brighton Jones LLC acquired a new stake in HCA Healthcare during the fourth quarter worth about $1,021,000. NewEdge Advisors LLC increased its position in shares of HCA Healthcare by 11.9% during the first quarter. NewEdge Advisors LLC now owns 3,859 shares of the company’s stock valued at $1,334,000 after acquiring an additional 409 shares during the last quarter. Sivia Capital Partners LLC increased its position in shares of HCA Healthcare by 5.5% during the second quarter. Sivia Capital Partners LLC now owns 630 shares of the company’s stock valued at $241,000 after acquiring an additional 33 shares during the last quarter. Jump Financial LLC acquired a new stake in shares of HCA Healthcare during the second quarter valued at about $2,073,000. Finally, Sei Investments Co. increased its position in shares of HCA Healthcare by 56.3% during the second quarter. Sei Investments Co. now owns 136,589 shares of the company’s stock valued at $52,328,000 after acquiring an additional 49,214 shares during the last quarter. 62.73% of the stock is currently owned by institutional investors and hedge funds.

HCA Healthcare Stock Performance

NYSE:HCA opened at $430.99 on Wednesday. HCA Healthcare, Inc. has a 1 year low of $329.72 and a 1 year high of $556.52. The stock has a market cap of $96.36 billion, a P/E ratio of 14.82, a P/E/G ratio of 1.50 and a beta of 1.36. The stock has a 50-day simple moving average of $501.51 and a 200-day simple moving average of $486.12.

HCA Healthcare (NYSE:HCA) last posted its earnings results on Friday, April 24th. The company reported $7.15 earnings per share for the quarter, missing the consensus estimate of $7.19 by ($0.04). The business had revenue of $19.11 billion for the quarter, compared to analysts’ expectations of $19.09 billion. HCA Healthcare had a negative return on equity of 295.93% and a net margin of 8.89%.HCA Healthcare’s revenue for the quarter was up 4.3% compared to the same quarter last year. During the same quarter in the previous year, the firm earned $6.45 EPS. HCA Healthcare has set its FY 2026 guidance at 29.100-31.500 EPS. On average, equities research analysts predict that HCA Healthcare, Inc. will post 30.06 EPS for the current year.

HCA Healthcare Announces Dividend

The business also recently declared a quarterly dividend, which will be paid on Tuesday, June 30th. Shareholders of record on Tuesday, June 16th will be paid a $0.78 dividend. This represents a $3.12 annualized dividend and a yield of 0.7%. The ex-dividend date is Tuesday, June 16th. HCA Healthcare’s dividend payout ratio is currently 10.73%.

Analysts Set New Price Targets

A number of equities research analysts have weighed in on HCA shares. TD Cowen dropped their price target on shares of HCA Healthcare from $561.00 to $500.00 and set a “buy” rating for the company in a research report on Monday. Deutsche Bank Aktiengesellschaft lowered their price objective on shares of HCA Healthcare from $558.00 to $540.00 and set a “buy” rating for the company in a research note on Tuesday. Barclays lowered their price objective on shares of HCA Healthcare from $551.00 to $496.00 and set an “overweight” rating for the company in a research note on Monday. Sanford C. Bernstein lowered their price objective on shares of HCA Healthcare from $541.00 to $503.00 and set a “market perform” rating for the company in a research note on Tuesday. Finally, Wall Street Zen lowered shares of HCA Healthcare from a “strong-buy” rating to a “buy” rating in a research note on Saturday, February 14th. Sixteen investment analysts have rated the stock with a Buy rating, seven have given a Hold rating and one has assigned a Sell rating to the company’s stock. Based on data from MarketBeat.com, the company has a consensus rating of “Moderate Buy” and an average price target of $520.55.

Insider Activity at HCA Healthcare

In other HCA Healthcare news, SVP Jennifer Berres sold 8,020 shares of the stock in a transaction that occurred on Wednesday, February 11th. The shares were sold at an average price of $514.58, for a total value of $4,126,931.60. Following the transaction, the senior vice president directly owned 11,993 shares in the company, valued at $6,171,357.94. This represents a 40.07% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available at this hyperlink. Also, EVP Michael S. Cuffe sold 1,500 shares of the firm’s stock in a transaction that occurred on Tuesday, February 3rd. The stock was sold at an average price of $498.09, for a total transaction of $747,135.00. Following the transaction, the executive vice president owned 30,003 shares in the company, valued at approximately $14,944,194.27. This trade represents a 4.76% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. Over the last three months, insiders have sold 15,214 shares of company stock valued at $7,797,595. Company insiders own 1.50% of the company’s stock.

About HCA Healthcare

HCA Healthcare is a for?profit operator of healthcare facilities headquartered in Nashville, Tennessee. Founded in 1968, the company owns and operates a network of hospitals and related healthcare facilities and has grown through organic expansion and acquisitions to become a large provider of inpatient and outpatient services.

The company’s core activities include the operation of acute care hospitals, freestanding surgical and emergency centers, and outpatient clinics. HCA’s services encompass inpatient care, surgical services, emergency medicine, diagnostic imaging and laboratory testing, and various outpatient and ambulatory care offerings.